Results 201 to 210 of about 37,007 (262)

KDM4B/DHX9 promotes chemoresistance in small-cell lung cancer through the MYCN-driven signaling pathway. [PDF]

open access: yesOncogene
Lyu Q   +10 more
europepmc   +1 more source

The nociceptor primary cilium. [PDF]

open access: yesBrain
Ganter GK   +5 more
europepmc   +1 more source

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesCancer Chemother Pharmacol, 2016
Maughan BL   +13 more
europepmc   +1 more source

Growth plate cartilage-targeting nanoparticles for pharmacological treatment of hypochondroplasia. [PDF]

open access: yesBioact Mater
Ye SH   +14 more
europepmc   +1 more source

Refractory Morpheaform Basal Cell Carcinoma Successfully Treated with Oral Sonidegib. [PDF]

open access: yesClin Cosmet Investig Dermatol
Zhang Y   +6 more
europepmc   +1 more source

Dissection of Gαs and Hedgehog Signaling Cross-talk Reveals Therapeutic Opportunities to Target Hedgehog-Dependent Tumors. [PDF]

open access: yesCancer Res
Krantz S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy